[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Page 31988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-12796]



[[Page 31988]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Siegfried 
(USA), LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Siegfried (USA), LLC applied to be registered as a 
manufacturer of certain basic classes of narcotic or non-narcotic 
controlled substances. The DEA grants Siegfried (USA), LLC registration 
as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated December 23, 2013, and 
published in the Federal Register on January 8, 2014, 79 FR 1391, 
Siegfried (USA), LLC, 33 Industrial Park Road, Pennsville, New Jersey 
08070, applied to be registered as a manufacturer of certain basic 
classes of narcotic or non-narcotic controlled substances.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Siegfried (USA), LLC to manufacture the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verified the company's 
compliance with state and local laws, and reviewed the company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of narcotic or non-narcotic 
controlled substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Dihydromorphine (9145).....................  I
Hydromorphinol (9301)......................  I
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk (9273)............  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium tincture (9630)......................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans on manufacturing the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received.

    Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12796 Filed 6-2-14; 8:45 am]
BILLING CODE 4410-09-P